Lyell Immunopharma earnings beat by $0.22, revenue fell short of estimates — See source for full details.
$LYEL
Price history, market instrument context, member research, and related headlines in one place.
LYEL key statistics
Lyell Immunopharma, Inc. (LYEL) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $8.19, up $0.20 (2.50%) from the previous close of $7.99. It has traded between $7.76 and $8.44 in the latest session. Over the past year it has ranged from $7.20 to $45.00, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 325K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Related news
Lyell Immunopharma reports Q2 results — See source for full details.
Form 4 Lyell Immunopharma Inc For: 27 July — See source for full details.
Form 4 Lyell Immunopharma Inc For: 27 July — See source for full details.